BIIO (Bionovate Technologies) Other Stockholders Equity: $-0.00 Mil (As of Sep. 2021)


What is Bionovate Technologies Other Stockholders Equity?

Bionovate Technologies BIIO Other Stockholders Equity is $-0.00 Mil as of Sep. 2021.

Bionovate Technologies's Other Stockholders Equity for the quarter that ended in Sep. 2021 was $-0.00 Mil.

Bionovate Technologies's quarterly Other Stockholders Equity increased from Mar. 2021 ($-0.00 Mil) to Jun. 2021 ($0.00 Mil) but then declined from Jun. 2021 ($0.00 Mil) to Sep. 2021 ($-0.00 Mil).

Bionovate Technologies's annual Other Stockholders Equity declined from Jun. 2019 ($-0.00 Mil) to Jun. 2020 ($-0.00 Mil) but then increased from Jun. 2020 ($-0.00 Mil) to Jun. 2021 ($0.00 Mil).

Bionovate Technologies Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Bionovate Technologies's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionovate Technologies Other Stockholders Equity Chart

Bionovate Technologies Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only 0.00 -0.00 -0.00 -0.00 0.00

Bionovate Technologies Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 -0.00 0.00 -0.00

Bionovate Technologies Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Bionovate Technologies (BIIO) has a Other Stockholders Equity of $-0.00 Mil as of Sep. 2021. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Bionovate Technologies and its competitors.
Is Bionovate Technologies' Other Stockholders Equity too high?
Bionovate Technologies' current Other Stockholders Equity is $-0.00 Mil.
How does Bionovate Technologies' Other Stockholders Equity compare to ABT and MDT?
Bionovate Technologies' Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Bionovate Technologies and its competitors. Bionovate Technologies's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionovate Technologies stock overvalued right now?
Bionovate Technologies (BIIO) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Bionovate Technologies (BIIO), the current Other Stockholders Equity is $-0.00 Mil as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionovate Technologies Business Description

Address 950 W Bannock Street, Boise, ID, USA, 83702
Bionovate Technologies Corp operates in the medical devices and diagnostics sector with a focus on mobile technologies.